246 related articles for article (PubMed ID: 21198552)
1. Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.
Joh EH; Kim DH
Br J Pharmacol; 2011 Apr; 162(8):1731-42. PubMed ID: 21198552
[TBL] [Abstract][Full Text] [Related]
2. Kalopanaxsaponin B inhibits LPS-induced inflammation by inhibiting IRAK1 Kinase.
Joh EH; Jeong JJ; Kim DH
Cell Immunol; 2012 Sep; 279(1):103-8. PubMed ID: 23117333
[TBL] [Abstract][Full Text] [Related]
3. Penta-O-galloyl-β-D-glucose ameliorates inflammation by inhibiting MyD88/NF-κB and MyD88/MAPK signalling pathways.
Jang SE; Hyam SR; Jeong JJ; Han MJ; Kim DH
Br J Pharmacol; 2013 Nov; 170(5):1078-91. PubMed ID: 23941302
[TBL] [Abstract][Full Text] [Related]
4. Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-κB and MAPK pathways.
Jeong JJ; Jang SE; Hyam SR; Han MJ; Kim DH
Eur J Pharmacol; 2014 Oct; 740():652-61. PubMed ID: 24972244
[TBL] [Abstract][Full Text] [Related]
5. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
[TBL] [Abstract][Full Text] [Related]
6. Echinocystic acid, a metabolite of lancemaside A, inhibits TNBS-induced colitis in mice.
Hyam SR; Jang SE; Jeong JJ; Joh EH; Han MJ; Kim DH
Int Immunopharmacol; 2013 Feb; 15(2):433-41. PubMed ID: 23352442
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Re ameliorates inflammation by inhibiting the binding of lipopolysaccharide to TLR4 on macrophages.
Lee IA; Hyam SR; Jang SE; Han MJ; Kim DH
J Agric Food Chem; 2012 Sep; 60(38):9595-602. PubMed ID: 22849695
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages.
Jang SE; Hyam SR; Han MJ; Kim SY; Lee BG; Kim DH
J Appl Microbiol; 2013 Sep; 115(3):888-96. PubMed ID: 23742179
[TBL] [Abstract][Full Text] [Related]
9. Kalopanaxsaponin B Ameliorates TNBS-Induced Colitis in Mice.
Jeong JJ; Jang SE; Joh EH; Han MJ; Kim DH
Biomol Ther (Seoul); 2012 Sep; 20(5):457-62. PubMed ID: 24009834
[TBL] [Abstract][Full Text] [Related]
10. Soyasaponin I attenuates TNBS-Induced colitis in mice by inhibiting NF-κB pathway.
Lee IA; Park YJ; Yeo HK; Han MJ; Kim DH
J Agric Food Chem; 2010 Oct; 58(20):10929-34. PubMed ID: 20923188
[TBL] [Abstract][Full Text] [Related]
11. Soyasaponin Ab ameliorates colitis by inhibiting the binding of lipopolysaccharide (LPS) to Toll-like receptor (TLR)4 on macrophages.
Lee IA; Park YJ; Joh EH; Kim DH
J Agric Food Chem; 2011 Dec; 59(24):13165-72. PubMed ID: 22060784
[TBL] [Abstract][Full Text] [Related]
12. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
13. Arctigenin ameliorates inflammation in vitro and in vivo by inhibiting the PI3K/AKT pathway and polarizing M1 macrophages to M2-like macrophages.
Hyam SR; Lee IA; Gu W; Kim KA; Jeong JJ; Jang SE; Han MJ; Kim DH
Eur J Pharmacol; 2013 May; 708(1-3):21-9. PubMed ID: 23375938
[TBL] [Abstract][Full Text] [Related]
14. Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-κB and MAPK pathways.
Joh EH; Gu W; Kim DH
Biochem Pharmacol; 2012 Aug; 84(3):331-40. PubMed ID: 22564908
[TBL] [Abstract][Full Text] [Related]
15. Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.
Joh EH; Lee IA; Han SJ; Chae S; Kim DH
Int J Colorectal Dis; 2010 May; 25(5):545-51. PubMed ID: 19956958
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
Joh EH; Lee IA; Jung IH; Kim DH
Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY; Jeong JJ; Eun SH; Kim DH
Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
[TBL] [Abstract][Full Text] [Related]
18. Stauntoside B inhibits macrophage activation by inhibiting NF-κB and ERK MAPK signalling.
Liu J; Tang J; Zuo Y; Yu Y; Luo P; Yao X; Dong Y; Wang P; Liu L; Zhou H
Pharmacol Res; 2016 Sep; 111():303-315. PubMed ID: 27343699
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages.
Jang SE; Han MJ; Kim SY; Kim DH
Int Immunopharmacol; 2014 Jul; 21(1):186-92. PubMed ID: 24815859
[TBL] [Abstract][Full Text] [Related]
20. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
Kang GD; Kim DH
J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]